Ozempic 0.25-0.5 MG/dose pen 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV584
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $65,086
Award facts
- Contract value 100% obligated
- $65,086.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $65,086.20 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) on January 15, 2026, with a completion date of January 16, 2026. This firm fixed-price contract, which was competitively awarded with no set-aside designation, represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical. The IDC, valued at up to $999.999 billion through December 2031, serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement needs across the military and veteran healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains, including diabetes medications, neurological treatments, pain management products, and specialized medical supplies. This delivery order for Ozempic, an injectable diabetes medication, reflects the company's ongoing role in supplying essential pharmaceutical commodities to support Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FV584?
SPE2DR26FV584 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FV584 worth?
The government has obligated $65,086 on SPE2DR26FV584.
Is contract SPE2DR26FV584 an order under another contract?
Yes. SPE2DR26FV584 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV584 competed?
The extent of competition for SPE2DR26FV584 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award